Patient Guide: A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 13 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07214727
Status: NOT_YET_RECRUITING
Condition: Alzheimer's Disease
Phase: PHASE1

Where You Can Participate

This study is available at 13 locations across the country.

Top locations include:
  • • Ottawa, Ontario
  • • Toronto, Ontario
  • • Toronto, Ontario
  • • And 10 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease - Join Clinical Trial NCTNCT07214727

How to Join This Clinical Trial - NCTNCT07214727

Learn how to participate in this PHASE1 trial studying an investigational therapy for Alzheimer's Disease. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Alzheimer's Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Alzheimer's Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07214727 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 13 locations. Find a study site near you:

Clinical Research Site

Ottawa, Ontario K1Z 1G3c - Canada

Status: Contact for availability

Clinical Research Site

Toronto, Ontario M3B 257 - Canada

Status: Contact for availability

Clinical Research Site

Toronto, Ontario M5T 2S8 - Canada

Status: Contact for availability

Clinical Research Site

's-Hertogenbosch, 5223 LA - Netherlands

Status: Contact for availability

Clinical Research Site

Amsterdam, 1081 GN - Netherlands

Status: Contact for availability

Clinical Research Site

Barcelona, 8036 - Spain

Status: Contact for availability

Clinical Research Site

Catalonia, 08195 - Spain

Status: Contact for availability

Clinical Research Site

Madrid, 28040 - Spain

Status: Contact for availability

Clinical Research Site

Glasgow, G15 6PX - United Kingdom

Status: Contact for availability

Clinical Research Site

London, WC1N 3BG - United Kingdom

Status: Contact for availability

And 3 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Alzheimer's Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships